Quidditas Therapeutics

Montlhéry, France

Quidditas Therapeutics develops an alternative technology which permits an absolute genetic recombination.

$1.9M raised

May 2025

Grant

Biotechnology Life Science

Top Investors

IncubAlliance Paris-Saclay Key Ventures iX Life Win4Company

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quidditas Therapeutics

How much funding has Quidditas Therapeutics raised?

Quidditas Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in May 2025.

Who are Quidditas Therapeutics's investors?

Quidditas Therapeutics's investors include IncubAlliance Paris-Saclay, Key Ventures, iX Life, Win4Company.

Where is Quidditas Therapeutics headquartered?

Quidditas Therapeutics is headquartered in Montlhéry, France.

What does Quidditas Therapeutics do?

Quidditas Therapeutics develops an alternative technology which permits an absolute genetic recombination.

What stage is Quidditas Therapeutics at?

Quidditas Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 12, 2025.

MLA

"Quidditas Therapeutics — Funding & Investors." VCBacked, May 12, 2025, https://www.vcbacked.co/company/quidditas-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Quidditas Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/quidditas-therapeutics

Wikipedia (cite web)

{{cite web |title=Quidditas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quidditas-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 12, 2025.